{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:13Z","timestamp":1790403013369,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["Grant number MC_UU_12023\/28"],"award-info":[{"award-number":["Grant number MC_UU_12023\/28"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41416-018-0273-9","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T07:29:35Z","timestamp":1542871775000},"page":"256-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis"],"prefix":"10.1038","volume":"120","author":[{"given":"Duncan C.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Wakeham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"273_CR1","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer, M. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob. Health 4, e609\u2013e616 (2016).","journal-title":"Lancet Glob. Health"},{"key":"273_CR2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H Vuyst De","year":"2009","unstructured":"De Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M. & Franceschi, S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 124, 1626\u20131636 (2009).","journal-title":"Int. J. Cancer"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/cam4.1108","volume":"6","author":"RF Koncar","year":"2017","unstructured":"Koncar, R. F., Feldman, R., Bahassi, E. M. & Hashemi Sadraei, N. Comparative molecular profiling of HPV-induced squamous cell carcinomas. Cancer Med. 6, 1673\u20131685 (2017).","journal-title":"Cancer Med."},{"key":"273_CR4","doi-asserted-by":"publisher","first-page":"485.e1","DOI":"10.1016\/j.ajog.2009.06.015","volume":"201","author":"N Bansal","year":"2009","unstructured":"Bansal, N. et al. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am. J. Obstet. Gynecol. 201, 485.e1\u2013e9 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"273_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/DCR.0000000000000058","volume":"57","author":"SE Goldstone","year":"2014","unstructured":"Goldstone, S. E., Johnstone, A. A. & Moshier, E. L. Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis. Colon Rectum 57, 316\u2013323 (2014).","journal-title":"Dis. Colon Rectum"},{"key":"273_CR6","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","volume":"32","author":"KK Ang","year":"2014","unstructured":"Ang, K. K. et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J. Clin. Oncol. 32, 2940\u20132950 (2014).","journal-title":"J. Clin. Oncol."},{"key":"273_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James, R. D. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 14, 516\u2013524 (2013).","journal-title":"Lancet Oncol."},{"key":"273_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1158\/1055-9965.EPI-10-0394","volume":"19","author":"AB Moscicki","year":"2010","unstructured":"Moscicki, A. B. et al. The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol. Biomark. Prev. 19, 2055\u20132065 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"273_CR9","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1158\/0008-5472.CAN-14-0602-T","volume":"74","author":"C Levovitz","year":"2014","unstructured":"Levovitz, C. et al. TGFbeta receptor 1: an immune susceptibility gene in HPV-associated cancer. Cancer Res. 74, 6833\u20136844 (2014).","journal-title":"Cancer Res."},{"key":"273_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/jnci\/djt051","volume":"105","author":"D Chen","year":"2013","unstructured":"Chen, D. et al. Genome-wide association study of susceptibility loci for cervical cancer. J. Natl. Cancer Inst. 105, 624\u2013633 (2013).","journal-title":"J. Natl. Cancer Inst."},{"issue":"4 Suppl","key":"273_CR11","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/1097-0142(197710)40:4+<1892::AID-CNCR2820400820>3.0.CO;2-H","volume":"40","author":"BS Schoenberg","year":"1977","unstructured":"Schoenberg, B. S. & Myers, M. H. Statistical methods for studying multiple primary malignant neoplasms. Cancer 40(4 Suppl), 1892\u20131898 (1977).","journal-title":"Cancer"},{"key":"273_CR12","unstructured":"Wells, G. A., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed 2017. \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008\u20132012 (2000).","journal-title":"JAMA"},{"key":"273_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian, R. & Kacker, R. Random-effects model for meta-analysis of clinical trials: an update. Contemp. Clin. Trials 28, 105\u2013114 (2007).","journal-title":"Contemp. Clin. Trials"},{"key":"273_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/1536867X1501500203","volume":"15","author":"DJ Fisher","year":"2015","unstructured":"Fisher, D. J. Two-stage individual participant data meta-analysis and generalised forest plots. STATA J. 15, 369\u2013396 (2015).","journal-title":"STATA J."},{"key":"273_CR17","first-page":"90","volume":"56","author":"JH Robertson","year":"1987","unstructured":"Robertson, J. H., Woodend, B. E., Crozier, E. H. & Patterson, A. Risk of recurrence after treatment of severe intraepithelial neoplasia of the cervix. A follow-up of 896 patients. Ulst. Med. J. 56, 90\u201394 (1987).","journal-title":"Ulst. Med. J."},{"key":"273_CR18","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/ijc.21604","volume":"118","author":"WP Soutter","year":"2006","unstructured":"Soutter, W. P., Sasieni, P. & Panoskaltsis, T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int. J. Cancer 118, 2048\u20132055 (2006).","journal-title":"Int. J. Cancer"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1471-0528.1989.tb02429.x","volume":"96","author":"SE Pearson","year":"1989","unstructured":"Pearson, S. E., Whittaker, J., Ireland, D. & Monaghan, J. M. Invasive cancer of the cervix after laser treatment. Br. J. Obstet. Gynaecol. 96, 486\u2013488 (1989).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"273_CR20","first-page":"451","volume":"64","author":"WA McIndoe","year":"1984","unstructured":"McIndoe, W. A., McLean, M. R., Jones, R. W. & Mullins, P. R. The invasive potential of carcinoma in situ of the cervix. Obstet. Gynecol. 64, 451\u2013458 (1984).","journal-title":"Obstet. Gynecol."},{"key":"273_CR21","first-page":"125","volume":"48","author":"P Kolstad","year":"1976","unstructured":"Kolstad, P. & Klem, V. Long-term follow up of 1121 cases of carcinoma in situ. Obstet. Gynecol. 48, 125\u2013129 (1976).","journal-title":"Obstet. Gynecol."},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000299517","volume":"13","author":"B Andersch","year":"1982","unstructured":"Andersch, B. & Moinian, M. Diagnostic and therapeutic viewpoints on cervical intraepithelial neoplasia. 10-Year follow-up of a conization material. Gynecol. Obstet. Invest. 13, 193\u2013205 (1982).","journal-title":"Gynecol. Obstet. Invest."},{"key":"273_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1309\/AJCPH4AFSZHU8EKK","volume":"140","author":"Z Li","year":"2013","unstructured":"Li, Z., Barron, S., Hong, W., Karunamurthy, A. & Zhao, C. Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful? Am. J. Clin. Path. 140, 708\u2013714 (2013).","journal-title":"Am. J. Clin. Path."},{"key":"273_CR24","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/ijc.25480","volume":"128","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Prevalence of multiple malignancies in the Netherlands in 2007. Int. J. Cancer 128, 1659\u20131667 (2011).","journal-title":"Int. J. Cancer"},{"key":"273_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","volume":"45","author":"HP Nieuwenhof van de","year":"2009","unstructured":"van de Nieuwenhof, H. P. et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur. J. Cancer 45, 851\u2013856 (2009).","journal-title":"Eur. J. Cancer"},{"key":"273_CR26","first-page":"13","volume":"81","author":"MF Mitchell","year":"1993","unstructured":"Mitchell, M. F. et al. Second genital primary squamous neoplasms in vulvar carcinoma: viral and histopathologic correlates. Obstet. Gynecol. 81, 13\u201318 (1993).","journal-title":"Obstet. Gynecol."},{"key":"273_CR27","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/lary.24719","volume":"124","author":"MS Tiwana","year":"2014","unstructured":"Tiwana, M. S. et al. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years. Laryngoscope 124, 2287\u20132291 (2014).","journal-title":"Laryngoscope"},{"key":"273_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijom.2008.12.015","volume":"38","author":"IS Haring van der","year":"2009","unstructured":"van der Haring, I. S., Schaapveld, M. S., Roodenburg, J. L. & de Bock, G. H. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int. J. Oral Maxillofac. Surg. 38, 332\u2013338 (2009).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"273_CR29","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/cncr.28107","volume":"119","author":"SJ Gan","year":"2013","unstructured":"Gan, S. J. et al. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119, 2593\u20132601 (2013).","journal-title":"Cancer"},{"key":"273_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00784-003-0246-z","volume":"8","author":"FJ Kramer","year":"2004","unstructured":"Kramer, F. J., Janssen, M. & Eckardt, A. Second primary tumours in oropharyngeal squamous cell carcinoma. Clin. Oral Invest. 8, 56\u201362 (2004).","journal-title":"Clin. Oral Invest."},{"key":"273_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7","volume":"21","author":"X Leon","year":"1999","unstructured":"Leon, X. et al. Second neoplasm in patients with head and neck cancer. Head Neck 21, 204\u2013210 (1999).","journal-title":"Head Neck"},{"key":"273_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1726-4901(08)70080-7","volume":"71","author":"YB Hsu","year":"2008","unstructured":"Hsu, Y. B. et al. Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J. Chin. Med. Assoc. 71, 86\u201391 (2008).","journal-title":"J. Chin. Med. Assoc."},{"key":"273_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/gyno.1997.4931","volume":"68","author":"E Crocetti","year":"1998","unstructured":"Crocetti, E. & Barchielli, A. Risk of metachronous primary cancers in women with cervical tumor\u2014an Italian population-based study. Gynecol. Oncol. 68, 215\u2013216 (1998).","journal-title":"Gynecol. Oncol."},{"key":"273_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/jnci\/djp089","volume":"101","author":"J Melnikow","year":"2009","unstructured":"Melnikow, J., McGahan, C., Sawaya, G. F., Ehlen, T. & Coldman, A. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J. Natl. Cancer Inst. 101, 721\u2013728 (2009).","journal-title":"J. Natl. Cancer Inst."},{"key":"273_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0167-8140(89)90028-5","volume":"16","author":"F Pettersson","year":"1989","unstructured":"Pettersson, F. & Malker, B. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry. Radiother. Oncol. 16, 115\u2013120 (1989).","journal-title":"Radiother. Oncol."},{"key":"273_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.radonc.2014.04.011","volume":"111","author":"M Arnold","year":"2014","unstructured":"Arnold, M. et al. Second primary cancers in survivors of cervical cancer in The Netherlands: implications for prevention and surveillance. Radiother. Oncol. 111, 374\u2013381 (2014).","journal-title":"Radiother. Oncol."},{"issue":"10 Suppl","key":"273_CR37","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1002\/cncr.23746","volume":"113","author":"A Balamurugan","year":"2008","unstructured":"Balamurugan, A. et al. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 113(10 Suppl), 2919\u20132925 (2008).","journal-title":"Cancer"},{"key":"273_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-94","volume":"14","author":"J Jegu","year":"2014","unstructured":"Jegu, J. et al. The effect of patient characteristics on second primary cancer risk in France. Bmc Cancer 14, 94 (2014).","journal-title":"Bmc Cancer"},{"key":"273_CR39","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/cncr.2820360933","volume":"36","author":"GR Newell","year":"1975","unstructured":"Newell, G. R., Krementz, E. T. & Roberts, J. D. Excess occurrence of cancer of the oral cavity, lung, and bladder following cancer of the cervix. Cancer 36, 2155\u20132158 (1975).","journal-title":"Cancer"},{"key":"273_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0002-9378(96)70328-9","volume":"174","author":"SR Sturgeon","year":"1996","unstructured":"Sturgeon, S. R., Curtis, R. E., Johnson, K., Ries, L. & Brinton, L. A. Second primary cancers after vulvar and vaginal cancers. Am. J. Obstet. Gynecol. 174, 929\u2013933 (1996).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"273_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0360-3016(82)90514-4","volume":"8","author":"DS Kapp","year":"1982","unstructured":"Kapp, D. S., Fischer, D., Grady, K. J. & Schwartz, P. E. Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies. Int. J. Radiat. Oncol. Biol. Phys. 8, 197\u2013205 (1982).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"273_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0360-3016(82)90515-6","volume":"8","author":"JY Lee","year":"1982","unstructured":"Lee, J. Y., Perez, C. A., Ettinger, N. & Fineberg, B. B. The risk of second primaries subsequent to irradiation for cervix cancer. Int. J. Radiat. Oncol. Biol. Phys. 8, 207\u2013211 (1982).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"273_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.2910620108","volume":"62","author":"T Bjorge","year":"1995","unstructured":"Bjorge, T., Hennig, E. M., Skare, G. B., Soreide, O. & Thoresen, S. O. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970\u20131992. Int. J. Cancer 62, 29\u201333 (1995).","journal-title":"Int. J. Cancer"},{"key":"273_CR44","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jnci\/djm201","volume":"99","author":"AK Chaturvedi","year":"2007","unstructured":"Chaturvedi, A. K. et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J. Natl. Cancer Inst. 99, 1634\u20131643 (2007).","journal-title":"J. Natl. Cancer Inst."},{"key":"273_CR45","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1200\/JCO.2008.18.4549","volume":"27","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi, A. K. et al. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J. Clin. Oncol. 27, 967\u2013973 (2009).","journal-title":"J. Clin. Oncol."},{"key":"273_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ygyno.2012.09.004","volume":"127","author":"CY Chen","year":"2012","unstructured":"Chen, C. Y. et al. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period. Gynecol. Oncol. 127, 625\u2013630 (2012).","journal-title":"Gynecol. Oncol."},{"key":"273_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1470-2045(07)70043-8","volume":"8","author":"G Edgren","year":"2007","unstructured":"Edgren, G. & Sparen, P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 8, 311\u2013316 (2007).","journal-title":"Lancet Oncol."},{"key":"273_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0090-8258(03)00231-2","volume":"90","author":"HS Evans","year":"2003","unstructured":"Evans, H. S., Newnham, A., Hodgson, S. V. & Moller, H. Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol. Oncol. 90, 131\u2013136 (2003).","journal-title":"Gynecol. Oncol."},{"key":"273_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/gyno.1996.4551","volume":"64","author":"G Fisher","year":"1997","unstructured":"Fisher, G., Harlow, S. D. & Schottenfeld, D. Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985\u20131992. Gynecol. Oncol. 64, 213\u2013223 (1997).","journal-title":"Gynecol. Oncol."},{"key":"273_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ygyno.2014.07.088","volume":"134","author":"M Gaudet","year":"2014","unstructured":"Gaudet, M., Hamm, J. & Aquino-Parsons, C. Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia. Gynecol. Oncol. 134, 523\u2013526 (2014).","journal-title":"Gynecol. Oncol."},{"key":"273_CR51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ijc.1319","volume":"93","author":"K Hemminki","year":"2001","unstructured":"Hemminki, K., Jiang, Y. & Dong, C. Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers: etiological links? Int. J. Cancer 93, 294\u2013298 (2001).","journal-title":"Int. J. Cancer"},{"key":"273_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00001648-200007000-00016","volume":"11","author":"K Hemminki","year":"2000","unstructured":"Hemminki, K., Dong, C. & Vaittinen, P. Second primary cancer after in situ and invasive cervical cancer. Epidemiology 11, 457\u2013461 (2000).","journal-title":"Epidemiology"},{"key":"273_CR53","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ijc.25428","volume":"128","author":"M Jakobsson","year":"2011","unstructured":"Jakobsson, M., Pukkala, E., Paavonen, J., Tapper, A. M. & Gissler, M. Cancer incidence among Finnish women with surgical treatment for cervical intraepithelial neoplasia, 1987\u22122006. Int. J. Cancer 128, 1187\u20131191 (2011).","journal-title":"Int. J. Cancer"},{"key":"273_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","volume":"331","author":"I Kalliala","year":"2005","unstructured":"Kalliala, I., Anttila, A., Pukkala, E. & Nieminen, P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 331, 1183\u20131185 (2005).","journal-title":"BMJ"},{"key":"273_CR55","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/bjc.1996.538","volume":"74","author":"F Levi","year":"1996","unstructured":"Levi, F., Randimbison, L., La Vecchia, C. & Franceschi, S. Incidence of invasive cancers following carcinoma in situ of the cervix. Br. J. Cancer 74, 1321\u20131323 (1996).","journal-title":"Br. J. Cancer"},{"key":"273_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4143\/crt.2014.326","volume":"48","author":"MC Lim","year":"2016","unstructured":"Lim, M. C. et al. Second primary cancer after diagnosis and treatment of cervical cancer. Cancer Res. Treat. 48, 641\u2013649 (2016).","journal-title":"Cancer Res. Treat."},{"key":"273_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF00053165","volume":"1","author":"H Mitchell","year":"1990","unstructured":"Mitchell, H., Medley, G. & Carlin, J. B. Risk of subsequent cytological abnormality and cancer among women with a history of cervical intraepithelial neoplasia: a comparative study. Cancer Causes Control 1, 143\u2013148 (1990).","journal-title":"Cancer Causes Control"},{"key":"273_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","volume":"90","author":"F Neumann","year":"2016","unstructured":"Neumann, F. et al. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study. Prev. Med. 90, 52\u201358 (2016).","journal-title":"Prev. Med."},{"key":"273_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/oxfordjournals.aje.a116420","volume":"136","author":"CS Rabkin","year":"1992","unstructured":"Rabkin, C. S., Biggar, R. J., Melbye, M. & Curtis, R. E. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am. J. Epidemiol. 136, 54\u201358 (1992).","journal-title":"Am. J. Epidemiol."},{"key":"273_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/hed.20663","volume":"30","author":"CC Rose Ragin","year":"2008","unstructured":"Rose Ragin, C. C. & Taioli, E. Second primary head and neck tumor risk in patients with cervical cancer\u2014SEER data analysis. Head Neck 30, 58\u201366 (2008).","journal-title":"Head Neck"},{"key":"273_CR61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","volume":"117","author":"AM Saleem","year":"2011","unstructured":"Saleem, A. M. et al. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet. Gynecol. 117, 643\u2013649 (2011).","journal-title":"Obstet. Gynecol."},{"key":"273_CR62","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/1055-9965.EPI-15-1291","volume":"25","author":"FL Sand","year":"2016","unstructured":"Sand, F. L. et al. Long-term risk for noncervical anogenital cancer in women with previously diagnosed high-grade cervical intraepithelial neoplasia: a Danish Nationwide Cohort Study. Cancer Epidemiol. Biomark. Prev. 25, 1090\u20131097 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"273_CR63","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","volume":"335","author":"B Strander","year":"2007","unstructured":"Strander, B., Andersson-Ellstrom, A., Milsom, I. & Sparen, P. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 335, 1077 (2007).","journal-title":"BMJ"},{"key":"273_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ygyno.2016.04.023","volume":"142","author":"MF Svahn","year":"2016","unstructured":"Svahn, M. F. et al. Risk of head-and-neck cancer following a diagnosis of severe cervical intraepithelial neoplasia: a nationwide population-based cohort study in Denmark. Gynecol. Oncol. 142, 128\u2013132 (2016).","journal-title":"Gynecol. Oncol."},{"key":"273_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/oxfordjournals.aje.a117154","volume":"140","author":"M Frisch","year":"1994","unstructured":"Frisch, M., Olsen, J. H. & Melbye, M. Malignancies that occur before and after anal cancer: clues to their etiology. Am. J. Epidemiol. 140, 12\u201319 (1994).","journal-title":"Am. J. Epidemiol."},{"key":"273_CR66","first-page":"4131","volume":"35","author":"BK Shah","year":"2015","unstructured":"Shah, B. K. & Budhathoki, N. Second primary malignancy in anal carcinoma\u2014a US population-based study. Anticancer Res. 35, 4131\u20134134 (2015).","journal-title":"Anticancer Res."},{"key":"273_CR67","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archoto.2009.19","volume":"135","author":"AG Sikora","year":"2009","unstructured":"Sikora, A. G., Morris, L. G. & Sturgis, E. M. Bidirectional association of anogenital and oral cavity\/pharyngeal carcinomas in men. Arch. Otolaryngol. Head Neck Surg. 135, 402\u2013405 (2009).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"273_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/014556130608500220","volume":"85","author":"N Bhattacharyya","year":"2006","unstructured":"Bhattacharyya, N. An assessment of risk factors for the development of a second primary malignancy in the head and neck. Ear Nose Throat J. 85, 121\u2013125 (2006).","journal-title":"Ear Nose Throat J."},{"key":"273_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ijc.25652","volume":"129","author":"C Bosetti","year":"2011","unstructured":"Bosetti, C. et al. High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int. J. Cancer 129, 173\u2013179 (2011).","journal-title":"Int. J. Cancer"},{"key":"273_CR70","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/ijc.23798","volume":"123","author":"SC Chuang","year":"2008","unstructured":"Chuang, S. C. et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int. J. Cancer 123, 2390\u20132396 (2008).","journal-title":"Int. J. Cancer"},{"key":"273_CR71","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/cncr.27988","volume":"119","author":"KS Jain","year":"2013","unstructured":"Jain, K. S., Sikora, A. G., Baxi, S. S. & Morris, L. G. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer 119, 1832\u20131837 (2013).","journal-title":"Cancer"},{"key":"273_CR72","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1002\/ijc.22183","volume":"119","author":"F Levi","year":"2006","unstructured":"Levi, F., Te, V. C., Randimbison, L., Maspoli, M. & La Vecchia, C. Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer. Int. J. Cancer 119, 2702\u20132704 (2006).","journal-title":"Int. J. Cancer"},{"key":"273_CR73","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1200\/JCO.2010.31.8311","volume":"29","author":"LG Morris","year":"2011","unstructured":"Morris, L. G., Sikora, A. G., Patel, S. G., Hayes, R. B. & Ganly, I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J. Clin. Oncol. 29, 739\u2013746 (2011).","journal-title":"J. Clin. Oncol."},{"key":"273_CR74","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/bjc.1994.148","volume":"69","author":"AL Soderholm","year":"1994","unstructured":"Soderholm, A. L., Pukkala, E., Lindqvist, C. & Teppo, L. Risk of new primary cancer in patients with oropharyngeal cancer. Br. J. Cancer 69, 784\u2013787 (1994).","journal-title":"Br. J. Cancer"},{"key":"273_CR75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C Martel de","year":"2017","unstructured":"de Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer 141, 664\u2013670 (2017).","journal-title":"Int. J. Cancer"},{"key":"273_CR76","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","volume":"121","author":"T Grantzau","year":"2016","unstructured":"Grantzau, T. & Overgaard, J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients. Radiother. Oncol. 121, 402\u2013413 (2016).","journal-title":"Radiother. Oncol."},{"key":"273_CR77","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41416-018-0176-9","volume":"119","author":"S Pernot","year":"2018","unstructured":"Pernot, S. et al. Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men. Br. J. Cancer 119, 381\u2013386 (2018).","journal-title":"Br. J. Cancer"},{"key":"273_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-946","volume":"13","author":"DA Machalek","year":"2013","unstructured":"Machalek, D. A. et al. The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. Bmc Public Health 13, 946 (2013).","journal-title":"Bmc Public Health"},{"key":"273_CR79","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/cid\/cir1036","volume":"54","author":"KA Swedish","year":"2012","unstructured":"Swedish, K. A., Factor, S. H. & Goldstone, S. E. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin. Infect. Dis. 54, 891\u2013898 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"273_CR80","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","volume":"130","author":"WD Kang","year":"2013","unstructured":"Kang, W. D., Choi, H. S. & Kim, S. M. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol. Oncol. 130, 264\u2013268 (2013).","journal-title":"Gynecol. Oncol."},{"key":"273_CR81","doi-asserted-by":"publisher","first-page":"e1401","DOI":"10.1136\/bmj.e1401","volume":"344","author":"EA Joura","year":"2012","unstructured":"Joura, E. A. et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 344, e1401 (2012).","journal-title":"BMJ"},{"key":"273_CR82","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","volume":"386","author":"CL Trimble","year":"2015","unstructured":"Trimble, C. L. et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet 386, 2078\u20132088 (2015).","journal-title":"Lancet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0273-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:03:24Z","timestamp":1684602204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0273-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As a systematic review and meta-analysis, no ethical approval or consent to participate was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This work was supported by the Medical Research Council (grant number MC_UU_12023\/28).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}